Form 8-K - Current report:
SEC Accession No. 0001104659-16-093133
Filing Date
2016-02-02
Accepted
2016-02-02 10:46:05
Documents
2
Period of Report
2016-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-3394_18k.htm 8-K 18136
2 EX-99.1 a16-3394_1ex99d1.htm EX-99.1 4974
  Complete submission text file 0001104659-16-093133.txt   24422
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 161379663
SIC: 2834 Pharmaceutical Preparations